Omega-3 (EPA/DHA)
fish oil · EPA · DHA · omega-3 fatty acids
Marine omega-3 fatty acids promoted for heart, brain and 'anti-inflammatory' aging.
TypeSupplement / dietary
Grade
C
Limited
- Class
- Essential fatty acids
- Primary use
- Cardiometabolic & inflammatory support
- Evidence strength
- medium
- Last reviewed
- 2026-07-01
Bottom line
Clearly useful for lowering triglycerides and in specific high-risk cardiac settings — but as a broad longevity or heart-protection pill for healthy people, the large trials are underwhelming.
What the evidence says
Omega-3s (EPA/DHA) have one of the largest randomized-trial programs of any supplement, which is exactly why the honest read is measured. High-dose prescription EPA cut cardiovascular events in people with high triglycerides already on statins (the REDUCE-IT setting), but a large general-population prevention trial (VITAL) found no significant reduction in major cardiovascular events or cancer. Triglyceride-lowering is robust; effects on cognition and 'inflammaging' are mixed. Hence grade C: real, targeted benefits — not the universal longevity insurance it is often sold as.
Key studies
- [1]
VITAL — marine omega-3 for cardiovascular disease and cancer prevention · RCT
No significant reduction in major events in a general population.
PubMed ↗ - [2]
High-dose EPA in high-triglyceride patients on statins · RCT
Event reduction — but in a specific high-risk, high-dose setting.
PubMed ↗ - [3]
Omega-3 and cognitive aging · review
Mixed; no reliable benefit for preventing cognitive decline broadly.
PubMed ↗
Mechanism
EPA/DHA incorporate into cell membranes and feed eicosanoid and specialised pro-resolving mediator pathways, lowering triglycerides and modulating inflammation; they also change membrane fluidity and signalling.
Safety
Generally safe. High doses can cause a fishy aftertaste and GI upset, mildly prolong bleeding time, and were linked to a small increase in atrial fibrillation in some high-dose trials. Product quality and oxidation vary between brands.
Dosage context
Dietary guidance favours two oily-fish meals per week. Supplement trials span roughly 1–4 g/day of EPA+DHA; importantly, the cardiovascular-event evidence is specific to high-dose prescription EPA in high-triglyceride patients, not low-dose over-the-counter fish oil taken by everyone.
From the field
A molecule where the big population trials matter more than the mechanism. We keep it at C because 'good for triglycerides and specific patients' is true, while 'everyone should take it for longevity' isn't what the large RCTs show.